Codexis (CDXS) has disclosed a new risk, in the Capital Markets category.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Codexis faces significant business risks due to international trade policies, including tariffs, sanctions, and trade barriers, which could adversely impact its operations. The global economy’s inherent uncertainties, coupled with recent U.S. government tariffs and retaliatory measures by foreign governments, pose challenges to Codexis’s supply chain and cost structure. These developments may increase research and development expenses, disrupt supply chains, and place Codexis at a competitive disadvantage compared to companies in regions with more favorable trade relationships. The ongoing uncertainty in international trade policies could materially affect Codexis’s business, financial condition, and competitive position.
Overall, Wall Street has a Strong Buy consensus rating on CDXS stock based on 4 Buys and 1 Hold.
To learn more about Codexis’ risk factors, click here.